Qiu has over 10 years’ experience in Clinical Study development and execution. He started clinical research journal from Pfizer, which involved in the global clinical trial resulted the successful launch of Viagra (Sildenafil), followed by leading couple of clinical trials in Beijing Novartis Pharma Co., Ltd. Dr. Qiu then switched his gear to clinical validation of diagnostic platforms in academics and IVD industry, including Beckman Coulter and Leica Biosystems. Under his leadership, Leica Biosystems’ Digital Pathology system AT2 DX has been awarded FDA 510(k) clearance 90 days after submission.
